GLPG VS TDOC Stock Comparison

Performance

GLPG
75/100

GLPG returned -9.92% in the last 12 months. Based on SPY's performance of -13.22%, its performance is above average giving it a score of 74 of 100.

TDOC
10/100

TDOC returned -44.69% in the last 12 months. Based on SPY's performance of -20.80%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

GLPG
78/100

8 analysts offer 12-month price targets for GLPG. Together, they have an average target of 88.89, the most optimistic target put GLPG at 97 within 12-months and the most pessimistic has GLPG at 83.74.

TDOC
77/100

13 analysts offer 12-month price targets for TDOC. Together, they have an average target of 58.61, the most optimistic target put TDOC at 150 within 12-months and the most pessimistic has TDOC at 25.

Technicals

GLPG
71/100

GLPG receives a 71 of 100 based on 14 indicators. 9 are bullish, 3 are bearish.

TDOC
14/100

TDOC receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

Earnings

GLPG
10/100

GLPG has missed earnings 10 times in the last 20 quarters.

TDOC
41/100

TDOC has missed earnings 5 times in the last 20 quarters.

Profit

GLPG
40/100

Out of the last 20 quarters, GLPG has had 8 profitable quarters and has increased their profits year over year on 6 of them.

TDOC
10/100

Out of the last 20 quarters, TDOC has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

GLPG
50/100

GLPG has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.

TDOC
44/100

TDOC has had a lower than average amount of volatility over the last 12 months giving it a score of 43 of 100.

Sentiment

GLPG

"Sentiment" not found for GLPG

TDOC
70/100

TDOC had a bullish sentiment score of 70.13% across Twitter and StockTwits over the last 12 months. It had an average of 113.30 posts, 203.86 comments, and 658.03 likes per day.

All score calculations are broken down here to help you make more informed investing decisions

Galapagos NV Summary

Nasdaq / GLPG

Healthcare

Biotechnology

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Teladoc Health, Inc. Summary

New York Stock Exchange / TDOC

Healthcare

Medical - Healthcare Information Services

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Power up your portfolio